ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2012

Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model.

Yohei Mineharu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.